Mylan NV (NASDAQ:MYL)

76.06
Delayed Data
As of Apr 24
 +2.37 / +3.22%
Today’s Change
44.80
Today|||52-Week Range
76.69
+34.93%
Year-to-Date

Today’s Trading

Previous close73.69
Today’s open73.58
Day’s range72.71 - 76.69
Volume12,236,778
Average volume (3 months)7,962,197
Market cap$37.2B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+15.96%
Earnings growth (next 5 years)+11.45%
Revenue growth (last year)+11.45%
P/E ratio32.8
Price/Sales2.71
Price/Book8.77

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-4.50-2.44%
VRTXVertex Pharmaceutica...-2.62-1.93%
PRGOPerrigo Company PLC-8.74-4.33%
SHPGShire-0.26-0.10%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.73
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers